TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank17
Studio
Year-over-Year Change

Free cash flow yield

Latest
-107.60%
↓ 84% vs avg
Percentile
P17
Within normal range
Streak
2 yr
Consecutive declineCompressed
Average
-58.63%
Historical baseline
PeriodValueYoY Change
2025-107.60%-219.5%
2024-33.68%-99.7%
2023-16.87%+91.1%
2022-189.75%-248.3%
2021-54.49%-1864.9%
2020-2.77%+47.3%
2019-5.26%-